Diet Of Ultra-Processed Foods Linked to Higher Depression Risk Long Term

Health & Lifestyle
332

Listen to article (english)

Translate to Spanish or other 102 languages!

Ultra-processed food consumption is linked to a higher risk of mental health problems in the long term. Image for illustration purposes
Ultra-processed food consumption is linked to a higher risk of mental health problems in the long term. Image for illustration purposes

Medical News Today

- Advertisement -
  • The more that a person’s daily calories come from ultra-processed foods, the more likely they are to experience depression long-term, a new study suggests.
  • The association between these foods and depression persisted regardless of sex, body mass index, age, marital status, social living situation, or level of physical activity.
  • Australia’s population gets a high percentage of their daily calories from ultra-processed foods, but residents of the United States and the United Kingdom residents get even more.

According to a new study from Australia, whose results appear in the Journal of Affective Disorders, people who consume a diet high in ultra-processed foods are more likely to experience depression as much as a decade later.

Follow the link below to read the full story on Medical News Today:

https://www.medicalnewstoday.com/articles/diet-of-ultra-processed-foods-linked-to-higher-depression-risk-long-term?utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2023-08-29&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source; https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
A Step Forward: Legislation Eliminating Sales Tax on Menstrual Products and Baby Supplies Goes into Effect, Sept. 1st
Next article
Joining Forces for Cancer Survivorship Education in the RGV, Sept. 19th

More Articles

FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk 

The U.S. Food and Drug Administration today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke (a stroke caused by a clot that did not originate in the heart) or a high-risk transient ischemic attack (TIA), often called a “mini-stroke.” 

Practical Health Tips to Navigate Cold and Flu Season Safely

With cold and flu season in full swing, experts say there are some simple steps you can take to protect yourself and those around you.

New Therapy for Head and Neck Squamous Cell Carcinoma Receives Accelerated FDA Approval

The U.S. Food and Drug Administration today granted accelerated approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for the treatment of adults with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) whose disease has progressed on or after platinum-based chemotherapy and immunotherapy.

DHR Health to Host 13th Annual Circle of Care Caregivers Conference

DHR Health Rehabilitation Hospital will host its 13th Annual Circle of Care Caregivers Conference on Saturday, November 7, 2026, at the Edinburg Conference Center at Renaissance, offering educational presentations and resources for individuals caring for family members and loved ones.
- Advertisement -